Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Na­tion­al Pro­ce­dure

In the national procedure pursuant to the Animal Health Act (Tiergesundheitsgesetz, TierGesG) in conjunction with the Animal Vaccine Regulation, the Paul-Ehrlich-Institut (PEI) assesses the quality, safety, environmental compatibility and efficacy of the immunological veterinary product for which a marketing authorisation has been applied, independently of other European regulatory authorities.

This type of procedure may be used for veterinary medicinal products which are not yet authorised in a Member State of the European Union (EU) or the European Economic Area (EEA). If the pharmaceutical operator already has an authorisation for the veterinary medicinal product in another EU / EEA Member State, authorisation must be granted in the mutual recognition procedure.

Updated: 21.11.2019